John T. French, MD joined the cancer care team of Northwest Georgia Oncology Centers, P.C. in September 2016 upon completion of his fellowship in Medical Oncology and Hematology at the MD Anderson Cancer Center in Houston, TX in June 2016. He completed his internship and residency at Vanderbilt University Medical Center in Nashville, TN in June 2013 and received his Doctorate of Medicine from the Medical College of Georgia in May 2010.
He is actively involved in cancer research and clinical trials to provide his patients with the most advanced cancer treatment available in Georgia as an Investigator of the William S. Gibbons Cancer Research Institute.
Dr. French provides patient-centered cancer care at NGOC’s Marietta Cancer Center and Jasper Cancer Center.
| Personal Data | Birthplace: Toledo, OH |
| Undergraduate Education | B.S., Cellular Biology, May 2006 University of Georgia Athens, GA |
| Medical Education | Doctor of Medicine, May 2010 Medical College of Georgia Augusta, GA |
| Postdoctoral Training | INTERNSHIP Internal Medicine Vanderbilt University, Medical Center Nashville, TN July 2010 - June 2011 RESIDENCY Internal Medicine Vanderbilt University, Medical Center Nashville, TN July 2011 – June 2013 FELLOWSHIP Hematology & Medical Oncology MD Anderson Cancer Center Houston, TX July 2013 - June 2016 |
| Board Certification | American Board of Internal Medicine, Internal Medicine, 2013 American Board of Internal Medicine, Medical Oncology, 2016 American Board of Internal Medicine, Hematology, 2016 |
| Medical Licensure | State of Georgia (April 2016) |
| Professional Societies | American Society of Clinical Oncology American Society of Hematology MD Anderson House Staff Senate National Cancer Institute, Pending |
| Honors | Association of Pathology Chairs Honor Society, 2008 Dean's Summer Research Fellowship, 2007 Research Internship in Science and Engineering (RISE) Scholarship, 2005 |
| Publications | K. Raghav, J. French, N. Ueno, L. Xiudong, S. Krishnamruthy, J. Reuben, V. Valero, N. Ibrahim. Inflammatory Breast Cancer: A Distinct Clinicopathological Entity Transcending Histological Distinction. Breast Cancer Research and Treatment. Under Review. C. Barcenas, J. Wells, D. Chong, J. French, S. Looney, T. Samuel. Racial differences in breast cancer survival from the Medical College of Georgia tumor registry 1990-2005. Clinical Breast Cancer. 2010 February; 10(1): 59-63. G. Bagchi, J. Wu, J. French, J. Kim, NH Moniri, Y Daaka. Androgens transduce the G alphas-medicated activation of protein kinase A in prostate cells. Cancer Research. 2008 May; 68(9): 3225-31. Abstracts: John T. French, Kenneth R. Hess, Diane Liu, Kanwal Raghav, Gabriel N. Hortobagyi, Banu Arun, Vicente Valero, Naoto T. Ueno, Richardo H. Alvarez, Wendy W. Woodward, Bisrat G. Debeb, Stacy L. Moulder, Bora Liam, Debu Tripathy, Buhad K. Ibrahim. Development of CNS metastatasis and subsequent survival in patients with inflammatory breast cancer. American Society of Clinical Oncology Annual Meeting, Chicago, IL. J Clin Oncol 33, June 2015 (suppl: abstr 1586). Pallavi Sharma, Thomas A. Samuel, Jeremy Wells, Elaine Mebel, John T. French, Jennifer A. Crozier, Stephen W. Looney. Overall Survival Effect of Lower Chemotherapy Dosing in Extremely Obese (BMI≥35) Breast Cancer Patients Based on Adjusted BSA. Poster (Board 15 D). American Society of Clinical Oncology annual meeting in Chicago, IL. Journal of Clinical Oncology, 29 (Iss 15S), June 2011: Abstra 1047. Pallavi Sharma, Stephen W. Looney, Jeremy Wells, Elaine Mebel, John T, French, Jennifer A. Crozier, Thomas A. Samuel. Breast cancer patients with WHO class II obesity of greater (BMI≥35) have poorer overall survival after receiving chemotherapy compared to similar patients with lower body mass index. Poster Presentation & Discussion (#PD09-07) at 2010 San Antonio Breast Cancer Symposium, San Antonio, TX. Cancer Research, A Journal of the American Association for Cancer Research. 70 (24 Suppl), Dec 2010: Abstract nr PD09-07. |
| Major Research Interests | Clinical Trials (Oncology & Hematology) |